ShangPharma Innovation | Team Groups Executives in Residence
110
archive,tax-team_group,term-executives-in-residence,term-110,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,qode-content-sidebar-responsive,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive
 

Archive

Dr. Charles Yang has decades of international experience in the biopharmaceutical industry and academia. For the last seven years, Dr. Yang was the vice president of biology, and head of neuroscience, at Shanghai ChemPartner, where he managed a global partnership in the biology CRO business....

Dr. Kiron, based in San Jose, CA, is an experienced pharma/biotech executive with decades of experience from early drug discovery through late-stage clinical development, intellectual property, regulatory strategy and product commercialization. Dr. Kiron has consulted for dozens of life sciences companies, founded and led multiple...

Benson Tsang brings nearly 30 years of financial and general management experience to ShangPharma Innovation. He has served as an independent director of ShangPharma Corp. and previously held the role of chief financial officer at WuXi Pharmatech Inc., where he was instrumental in the company’s...

Dr. Brockstedt is executive vice president of research and development for Aduro Biotech, an immunotherapy company. Prior to joining Aduro in 2009, he held various positions at Cerus Corp., where he was a foundational member of the original immunotherapy group. Dr. Brockstedt previously served as...

Dr. Lutz founded Crescendo BioPharma Consulting and provides strategic, tactical, and operational expertise to help meet the needs of emerging biotechnology and pharmaceutical companies worldwide. He focuses on guiding transitions from discovery to clinical proof-of-concept. Previously, for more than 20 years, he was employed at...

Dr. Wild, based in San Diego, CA, is a seasoned R&D executive with almost 20 years of broad biotech/pharma industry experience in drug discovery and development, spanning both small molecules and biologics. He currently advises a number of biotechnology and pharmaceutical companies and investors. Dr....

Dr. Kodukula, based in Princeton, NJ, is a pharmaceutical professional with decades of experience in the biopharmaceutical and non-profit sectors, in research and business roles. Previously, he was Executive Director, Strategic Development at SRI Biosciences (Stanford Research Institute); Site Head and Founder of SRI Shenandoah...

Dr. Spellmeyer is a biotechnology executive with 25 years of broad experience in the life sciences industry. He currently serves as CSO at Circle Pharma, an SPII VC portfolio company and heads Interlaken Associates where he advises early-stage companies and investors on corporate and technical...

Mr. DiLaura is a life sciences executive based in San Francisco and he currently advises a number of biotechnology and pharmaceutical companies and investors. Formerly, he was CEO of Second Genome, a pioneering microbiome therapeutics company, from seed financing through clinical development. Previously, Mr. DiLaura...